Bis-aryloxadiazoles as effective activators of the aryl hydrocarbon receptor.
暂无分享,去创建一个
B. Welm | R. Looper | Kaitlin J. Basham | Vasudev R. Bhonde | Collin Kieffer | James B C Mack | M. Hess | James B. C. Mack | Kaitlin J Basham
[1] D. Shelton,et al. Chemical Genetic Screen Reveals a Role for Desmosomal Adhesion in Mammary Branching Morphogenesis , 2012, The Journal of Biological Chemistry.
[2] Annalisa Bordogna,et al. New Aryl Hydrocarbon Receptor Homology Model Targeted To Improve Docking Reliability , 2011, J. Chem. Inf. Model..
[3] R. Somani,et al. Synthesis and Evaluation of Antiinflammatory, Analgesic and Ulcerogenic Potential of NSAIDs Bearing 1,3,4-Oxadiazole Scaffold , 2011, Indian journal of pharmaceutical sciences.
[4] B. Lawrence,et al. Activation of the Aryl Hydrocarbon Receptor During Pregnancy in the Mouse Alters Mammary Development Through Direct Effects on Stromal and Epithelial Tissues1 , 2011, Biology of reproduction.
[5] Matthew E Welsch,et al. Privileged scaffolds for library design and drug discovery. , 2010, Current opinion in chemical biology.
[6] F. Whelan,et al. The pleiotropy of dioxin toxicity--xenobiotic misappropriation of the aryl hydrocarbon receptor's alternative physiological roles. , 2009, Pharmacology & therapeutics.
[7] A. Pace,et al. The new era of 1,2,4-oxadiazoles. , 2009, Organic & biomolecular chemistry.
[8] Lorenz M Mayr,et al. Novel trends in high-throughput screening. , 2009, Current opinion in pharmacology.
[9] B. Lawrence,et al. TCDD exposure disrupts mammary epithelial cell differentiation and function. , 2009, Reproductive toxicology.
[10] K. Shah,et al. Synthesis and anticancer activities of novel 3,5-disubstituted-1,2,4-oxadiazoles. , 2009, Bioorganic & medicinal chemistry letters.
[11] D. Hazuda,et al. Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infection. , 2008, Journal of medicinal chemistry.
[12] D. Garrod,et al. Desmosome structure, composition and function. , 2008, Biochimica et biophysica acta.
[13] Meenal Patel,et al. PTC124 targets genetic disorders caused by nonsense mutations , 2007, Nature.
[14] P. Boutros,et al. Aryl Hydrocarbon Receptor Regulates Distinct Dioxin-Dependent and Dioxin-Independent Gene Batteries , 2006, Molecular Pharmacology.
[15] S. A. Parent,et al. Discovery of potent 3,5-diphenyl-1,2,4-oxadiazole sphingosine-1-phosphate-1 (S1P1) receptor agonists with exceptional selectivity against S1P2 and S1P3. , 2005, Journal of medicinal chemistry.
[16] L. Qiu,et al. Discovery and structure-activity relationship of 3-aryl-5-aryl-1,2,4-oxadiazoles as a new series of apoptosis inducers and potential anticancer agents. , 2005, Journal of medicinal chemistry.
[17] P. Mandal. Dioxin: a review of its environmental effects and its aryl hydrocarbon receptor biology , 2005, Journal of Comparative Physiology B.
[18] N. Cosford,et al. Discovery of novel heteroarylazoles that are metabotropic glutamate subtype 5 receptor antagonists with anxiolytic activity. , 2004, Journal of medicinal chemistry.
[19] Jennifer A Cundiff,et al. A novel effect of dioxin: exposure during pregnancy severely impairs mammary gland differentiation. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.
[20] J. Whitlock,et al. Induction of cytochrome P4501A1. , 1999, Annual review of pharmacology and toxicology.